Unfolded protein response in myelin disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Activation of the unfolded protein response in response to endoplasmic reticulum stress preserves cell viability and function under stressful conditions. Nevertheless, persistent, unresolvable activation of the unfolded protein response can trigger apoptosis to eliminate stressed cells. Recent studies show that the unfolded protein response plays an important role in the pathogenesis of various disorders of myelin, including multiples sclerosis, Charcot-Marie-Tooth disease, Pelizaeus-Merzbacher disease, vanishing white matter disease, spinal cord injury, tuberous sclerosis complex, and hypoxia-induced perinatal white matter injury. In this review we summarize the current literature on the unfolded protein response and the evidence for its role in the pathogenesis of myelin disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
Protein misfolding in the endoplasmic reticulum as a conduit to human disease
Wang, M., & Kaufman, R. J. (2016) · Nature · doi:10.1038/nature17041 · Cited by 1,630 · cited 4×
“The UPR, which comprises three parallel signaling branches, pancreatic endoplasmic reticulum kinase (PERK), inositol-requiring enzyme 1 (IRE1), and activating transcription factor 6α (ATF6α), restores ER homeostasis by facilitating protein folding, attenuating protein translation, and enhancing protein degradation (Ma…”
BackgroundInfluentialHypoxia signalling through mTOR and the unfolded protein response in cancer
Wouters, B. G., & Koritzinsky, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2501 · Cited by 894 · cited 1×
“It is well known that activation of the UPR in response to hypoxia preserves cell viability and function (Koumenis et al., 2007; Wouters and Koritzinsky, 2008).”
BackgroundThe unfolded protein response signals through high-order assembly of Ire1
Korennykh, A. V., Egea, P. F., Korostelev, A. A., Finer-Moore, J., Zhang, C., Shokat, K. M., Stroud, R. M., & Walter, P. (2009) · Nature · doi:10.1038/nature07661 · Cited by 656
Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis
Falcão, A. M., van Bruggen, D., Marques, S., Meijer, M., Jäkel, S., Agirre, E., Samudyata, Floriddia, E. M., Vanichkina, D. P., ffrench-Constant, C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0236-y · Cited by 579
Multiple sclerosis: experimental models and reality
Lassmann, H., & Bradl, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1631-4 · Cited by 525
Papandreou, I., Denko, N. C., Olson, M., Van Melckebeke, H., Lust, S., Tam, A., Solow-Cordero, D. E., Bouley, D. M., Offner, F., Niwa, M., et al. (2011) · Blood · doi:10.1182/blood-2010-08-303099 · Cited by 489
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity
Atkins, C., Liu, Q., Minthorn, E., Zhang, S.-Y., Figueroa, D. J., Moss, K., Stanley, T. B., Sanders, B., Goetz, A., Gaul, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3109 · Cited by 443 · cited 1×
“GSK2606414 and GSK2656157 selectively bind to the eIF2α kinase domain of the PERK protein, suppress PERK-mediated eIF2α phosphorylation (Axten et al., 2012; Harding et al., 2012; Atkins et al., 2013).”
BackgroundMimura, N., Fulciniti, M., Gorgun, G., Tai, Y.-T., Cirstea, D., Santo, L., Hu, Y., Fabre, C., Minami, J., Ohguchi, H., et al. (2012) · Blood · doi:10.1182/blood-2011-07-366633 · Cited by 432 · cited 1×
“STF-083010, MKC-3946, and 4µ8c inhibit the endoribonuclease activity of IRE1 but not its ability to oligomerize and autophosphorylate (Papandreou et al., 2011; Mimura et al., 2012; Cross et al., 2012; Tam et al. 2014).”
BackgroundBrain injury in premature neonates: A primary cerebral dysmaturation disorder?
Back, S. A., & Miller, S. P. (2014) · Annals of Neurology · doi:10.1002/ana.24132 · Cited by 360 · cited 1×
“Hypoxia predominantly affects OPCs in PWMI, inducing OPC death and inhibiting their ability to differentiate into myelinating oligodendrocytes, resulting in myelin loss and decreased white matter (Volpe, 2009; Back and Miller, 2014).”
BackgroundeIF2B activator prevents neurological defects caused by a chronic integrated stress response
Wong, Y. L., LeBon, L., Basso, A. M., Kohlhaas, K. L., Nikkel, A. L., Robb, H. M., Donnelly-Roberts, D. L., Prakash, J., Swensen, A. M., Rubinstein, N. D., et al. (2019) · eLife · doi:10.7554/elife.42940 · Cited by 236 · cited 1×
“Interestingly, a recent report shows that treatment with 2BAct, a small molecule eIF2B activator, restores the activity of eIF2B and eliminates minor myelin abnormalities in the CNS of mice carrying a VWMD mutation (Wong et al., 2019).”
BackgroundLin, W., Kemper, A., Dupree, J. L., Harding, H. P., Ron, D., & Popko, B. (2006) · Brain · doi:10.1093/brain/awl044 · Cited by 222
Self-citationLeukoencephalopathy with vanishing white matter: a review
Bugiani, M., Boor, I., Powers, J. M., Scheper, G. C., & van der Knaap, M. S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181f2eafa · Cited by 189
Mháille, A. N., McQuaid, S., Windebank, A., Cunnea, P., McMahon, J., Samali, A., & FitzGerald, U. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318165b239 · Cited by 128
Diversity Matters: A Revised Guide to Myelination
Tomassy, G. S., Dershowitz, L. B., & Arlotta, P. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.09.002 · Cited by 115
Way, S. W., Podojil, J. R., Clayton, B. L., Zaremba, A., Collins, T. L., Kunjamma, R. B., Robinson, A. P., Brugarolas, P., Miller, R. H., Miller, S. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7532 · Cited by 108 · cited 5×
“…of MS, CMT1B, and SCI (Lin et al., 2008; D’Antonio et al., 2013; Ohri et al., 2013); 2) Guanabenz treatment is beneficial to animal models of MS and TSC (Way et al., 2015; Jiang et al., 2016); 3) Sephin1 treatment is beneficial to animal models of MS and CMT1B (Das et al., 2015; Chen et al., 2019).”
BackgroundInfluential
Cited by
De Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“Interestingly, dj1 is dysregulated in PD and upregulated in peripheral blood mononuclear cells (PBMCs) from MS [328,351].”
BackgroundWhite Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
García-Domínguez, M. (2025) · Cells · doi:10.3390/cells14181408 · Cited by 13
“However, prolonged or excessive UPR signaling results in sustained translational repression that suppresses synthesis of myelin proteins, further impairing remyelination [176].”
GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35
De Masi, R., & Orlando, S. (2021) · Pharmaceuticals · doi:10.3390/ph14111195 · Cited by 10
“Moreover, GANAB is involved in the endoplasmic reticulum (ER) stress response (ERSR), also called unfolded protein response (UPR) [15,16].”
BackgroundInfluential
Metadata
- Authors
- Lin, W., & Stone, S.
- Venue
- Neural Regeneration Research
- Publisher
- Medknow
- Published
- 2020
- Volume
- 15
- Issue
- 4
- Pages
- 636
- ISSN
- 1673-5374 (ISSN-L)
- OpenAlex
- W2981067496
- Cited by
- 55
- References
- 16
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.